Journal Article

ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK+ non-small cell lung cancer (NSCLC)

J. Wolf, I-J. Oh, J. Mazieres, J. de Castro, C. Revil, A. Kotb, H. Johansdottir, A. Zeaiter and S. Novello

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 27, issue suppl_6 Published in print October 2016 | ISSN: 0923-7534
Published online October 2016 | e-ISSN: 1569-8041 | DOI: http://dx.doi.org/10.1093/annonc/mdw383.90
ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK+ non-small cell lung cancer (NSCLC)

Show Summary Details

Journal Article.  428 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.